INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 34 filers reported holding INSMED INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $17,110,000 | +6.0% | 18,046,000 | +5.0% | 0.18% | +13.6% |
| Q2 2022 | $16,138,000 | -33.2% | 17,183,000 | -29.3% | 0.16% | -31.4% |
| Q1 2022 | $24,167,000 | -15.3% | 24,300,000 | -12.6% | 0.24% | -11.3% |
| Q4 2021 | $28,526,000 | +57.6% | 27,788,000 | +58.7% | 0.27% | +70.5% |
| Q3 2021 | $18,103,000 | +681.3% | 17,510,000 | +695.9% | 0.16% | +766.7% |
| Q2 2021 | $2,317,000 | -92.6% | 2,200,000 | -92.2% | 0.02% | -93.2% |
| Q1 2021 | $31,345,000 | -20.6% | 28,070,000 | -20.0% | 0.26% | -8.6% |
| Q4 2020 | $39,493,000 | +24.4% | 35,070,000 | +20.2% | 0.29% | +2.8% |
| Q3 2020 | $31,756,000 | +261.4% | 29,170,000 | +223.3% | 0.28% | +220.5% |
| Q2 2020 | $8,788,000 | +107.4% | 9,022,000 | +79.6% | 0.09% | +41.9% |
| Q1 2020 | $4,238,000 | -58.5% | 5,022,000 | -59.0% | 0.06% | -52.3% |
| Q3 2019 | $10,221,000 | – | 12,258,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
| Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
| LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
| ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
| DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
| Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
| Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
| Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |